ClinVar Miner

Submissions for variant NM_000393.5(COL5A2):c.2017C>A (p.Pro673Thr)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Molecular Genetics, Royal Melbourne Hospital RCV003994668 SCV004812540 uncertain significance Ehlers-Danlos syndrome, classic type 2024-03-01 criteria provided, single submitter clinical testing This sequence change in COL5A2 is predicted to replace proline with threonine at codon 673, p.(Pro673Thr). The proline residue is moderately conserved (100 vertebrates, Multiz Alignments), and is located in the disordered region of the gene. There is a small physicochemical difference between proline and threonine. This variant is absent from the population database gnomAD v4.0. To our knowledge, this variant is novel and has not been previously reported in the relevant scientific literature or databases. Computational evidence is uninformative for the missense substitution (REVEL = 0.455). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2_Supporting

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.